Sarah Jane Tribble
December 12, 2018

Kip Burgess was relieved last year when pharmaceutical giant Amgen overnighted him a $2,976 check to help pay for his go-to arthritis drug, Enbrel. The 36-year-old psychologist had run into an increasingly common problem: The copay coupon sent by Amgen couldn’t cover the drug’s more than $4,000 monthly price.
The drugmaker sent him the check after he provided a credit card statement and an explanation of benefits to prove he bought its drug.

Read more: